Table 4.
Predictor | Moderate (Hospitalized Non-ICU) N = 196 |
Severe (ICU Admission or Death) N = 78 |
||||||
---|---|---|---|---|---|---|---|---|
Estimates | SE | aOR (95% CI) | P Value | Estimates | SE | aOR (95% CI) | P Value | |
Age | 0.018 | 0.03 | 1.02 (0.96–1.09) | .571 | 0.121 | 0.05 | 1.13 (1.02–1.25) | .017 |
Male | 1.69 | 0.85 | 5.40 (1.01–28.76) | .048 | 1.66 | 1.15 | 5.25 (0.55–49.9) | .149 |
Black or African American | 1.66 | 0.76 | 5.28 (1.20–23.18) | .028 | 1.58 | 0.95 | 4.85 (0.75–31.29) | .097 |
Tenofovir use | 0.863 | 0.86 | 1.55 (0.29–8.43) | .609 | −0.541 | 1.03 | 0.58 (0.08–4.36) | .598 |
Protease inhibitor use | 1.039 | 1.05 | 2.83 (0.36–22.00) | .321 | 3.25 | 1.17 | 3.42 (0.34–34.04) | .295 |
Integrase inhibitor use | 3.03 | 1.33 | 20.77 (1.54–280.96) | .026 | 1.59 | 1.34 | 4.93 (0.36–67.57) | .223 |
CD4 <200 cells/mm3 | −2.56 | 0.88 | 12.50 (2.33–100.00) | .003 | −2.14 | 1.06 | 8.33 (1.06–50.00) | .044 |
Viral load >20 copies/mL | −0.039 | 0.96 | 0.962 (0.15–6.26) | .968 | 0.217 | 1.22 | 1.24 (0.11–13.69) | .859 |
Bold indicates statistically significant values.
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; COVID-19, coronavirus disease 2019; ICU, intensive care unit; PWH, people with human immunodeficiency virus; SE, standard error.